We are live on ! Find out more
AA

AlphaMark Advisors Portfolio holdings

AUM $231M
1-Year Est. Return 19.98%
This Fund
S&P 500
This Quarter Est. Return
+6.81%
1 Year Est. Return
+19.98%
3 Year Est. Return
+26.38%
5 Year Est. Return
+72.27%
10 Year Est. Return
+180.76%
AUM
$239M
AUM Growth
+$8.32M
Cap. Flow
-$5.16M
Cap. Flow %
-2.16%
Top 10 Hldgs %
35.11%
Holding
546
New
36
Increased
93
Reduced
108
Closed
33

Top Buys

Rank Stock Value
1
ALXN
Alexion Pharmaceuticals
ALXN
+$3.15M
2
BMY icon
Bristol-Myers Squibb
BMY
+$2.48M
3
DLTR icon
Dollar Tree
DLTR
+$1.94M
4
VTV icon
Vanguard Morningstar Value ETF
VTV
+$857K
5
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$833K

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$4.4M
2
EOG icon
EOG Resources
EOG
+$2.91M
3
UTHR icon
United Therapeutics
UTHR
+$2.5M
4
ZBRA icon
Zebra Technologies
ZBRA
+$1.98M
5
PVH icon
PVH
PVH
+$1.43M

Sector Composition

Rank Sector Weight
1 Financials 10.55%
2 Consumer Staples 7.28%
3 Technology 6.91%
4 Consumer Discretionary 6.75%
5 Industrials 6.42%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BDSI
376
DELISTED
BioDelivery Sciences International, Inc.
BDSI
$7K ﹤0.01%
1,100
– –
BAB icon
377
Invesco Taxable Municipal Bond ETF
BAB
$1.02B
$6K ﹤0.01%
180
– –
C icon
378
Citigroup
C
$222B
$6K ﹤0.01%
81
– –
CTVA icon
379
Corteva
CTVA
$52.6B
$6K ﹤0.01%
213
– –
FDN icon
380
First Trust Dow Jones Internet Index Fund ETF
FDN
$5.12B
$6K ﹤0.01%
40
– –
HMC icon
381
Honda
HMC
$39.1B
$6K ﹤0.01%
200
– –
HOG icon
382
Harley-Davidson
HOG
$2.58B
$6K ﹤0.01%
150
– –
IEUS icon
383
iShares MSCI Europe Small-Cap ETF
IEUS
$180M
$6K ﹤0.01%
109
+2
+2% +$104
IYZ icon
384
iShares US Telecommunications ETF
IYZ
$1.2B
$6K ﹤0.01%
200
– –
KRE icon
385
State Street SPDR S&P Regional Banking ETF
KRE
$4.5B
$6K ﹤0.01%
105
+1
+1% +$55
LIN icon
386
Linde
LIN
$221B
$6K ﹤0.01%
29
– –
MCHI icon
387
iShares MSCI China ETF
MCHI
$6.32B
$6K ﹤0.01%
100
– –
SND icon
388
Smart Sand
SND
$185M
$6K ﹤0.01%
2,350
– –
TGT icon
389
Target
TGT
$65.6B
$6K ﹤0.01%
44
– –
UGI icon
390
UGI
UGI
$7.74B
$6K ﹤0.01%
127
– –
CBB
391
DELISTED
Cincinnati Bell Inc.
CBB
$6K ﹤0.01%
600
-40
-6% -$245
ALC icon
392
Alcon
ALC
$33.6B
$5K ﹤0.01%
80
-25
-24% -$1.43K
AMRN
393
Amarin Corp
AMRN
$298M
$5K ﹤0.01%
13
– –
CCL icon
394
Carnival Corporation Ltd
CCL
$38.1B
$5K ﹤0.01%
+100
New +$4.47K
CSCO icon
395
Cisco
CSCO
$457B
$5K ﹤0.01%
100
– –
EDIT icon
396
Editas Medicine
EDIT
$396M
$5K ﹤0.01%
154
– –
EMHY icon
397
iShares JPMorgan EM High Yield Bond ETF
EMHY
$620M
$5K ﹤0.01%
100
– –
FCX icon
398
Freeport-McMoran
FCX
$90B
$5K ﹤0.01%
400
– –
FDS icon
399
Factset
FDS
$9.36B
$5K ﹤0.01%
19
– –
HPQ icon
400
HP
HPQ
$24.9B
$5K ﹤0.01%
+253
New +$4.79K
14 15
16
17 18

Similar funds

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
MWS
Maxwell Wealth Strategies Pleasanton, California $245M AUM 23.39% 1-Year Est. Return
LHR
Lunate Holding RSC Al Maryah Island, Abu Dhabi, United Arab Emirates $211M AUM
HPFG
Hart & Patterson Financial Group Amherst, Massachusetts $206M AUM 7.82% 1-Year Est. Return
GWM
Gray Wealth Management Bangor, Maine $264M AUM 19.5% 1-Year Est. Return
KC
Kades & Cheifetz Berwyn, Pennsylvania $195M AUM 11.87% 1-Year Est. Return
SL
SIB LLC New York, New York $190M AUM 9.27% 1-Year Est. Return
CSWM
Cassady Schiller Wealth Management Cincinnati, Ohio $273M AUM 17.91% 1-Year Est. Return

AlphaMark Advisors's Q4 2019 Portfolio in Review

As of Q4 2019, AlphaMark Advisors held 546 positions worth $239M, up 3.6% from $231M the previous quarter. Its ten largest holdings account for 35% of the portfolio.

AlphaMark Advisors's Q4 2019 filing shows 36 new, 93 increased, 108 reduced and 33 closed positions. Its largest new stake was Alexion Pharmaceuticals: 29,481 shares worth $3.19M. The largest sale was Celgene Corp, an estimated $4.4M.

By sector, the portfolio is most concentrated in Financials at 11% of assets, up from 10% a quarter earlier, followed by Consumer Staples and Technology.

  • AlphaMark Advisors's largest Q4 2019 buy was Alexion Pharmaceuticals: 29,481 shares worth $3.19M.
  • AlphaMark Advisors added most to Bristol-Myers Squibb in Q4 2019, an estimated $2.48M increase.
  • AlphaMark Advisors's biggest Q4 2019 reduction was EOG Resources, cutting an estimated $2.91M.
  • AlphaMark Advisors fully exited Celgene Corp in Q4 2019, selling an estimated $4.4M.
  • AlphaMark Advisors's ten largest holdings make up 35% of its $239M portfolio in Q4 2019.
  • AlphaMark Advisors opened 36 new positions and closed 33 in Q4 2019.
  • AlphaMark Advisors's portfolio value rose 3.6% quarter-over-quarter to $239M.

Based on AlphaMark Advisors's 13F filing for Q4 2019, filed 7 Feb 2020.